FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and concerns a composition and a method for preparing stable adjuvant mother solutions containing glycolipids, weak acids, alcohols, non-ionic surface-active substances and buffers.
EFFECT: invention provides the improved stability of the adjuvant glycolipid composition.
15 cl, 11 ex, 16 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NEW ADJUVANT COMPOSITIONS | 2009 |
|
RU2510280C2 |
| COMPOSITION BASED ON HEPATITIS B VIRUS (HBV) PROTEIN AND STRESS PROTEIN AND USES THEREOF | 2002 |
|
RU2295536C2 |
| FUNCTIONALLY RECONSTRUCTED ADJUVANT-CONTAINING VIRUS MEMBRANES | 2004 |
|
RU2348428C2 |
| METHODS OF OBTAINING PNEUMOCOCCAL POLYSACCHARIDES COMPOSITIONS FOR CONJUGATION WITH CARRIER PROTEIN | 2018 |
|
RU2805605C2 |
| PURIFICATION OF SACCHARIDES | 2021 |
|
RU2816593C1 |
| PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2604690C2 |
| LIQUID STABLE VIRAL VACCINES | 2013 |
|
RU2641970C2 |
| GLYCOLIPID COMPOUNDS AND USE THEREOF IN TREATING TUMOURS | 2015 |
|
RU2719486C2 |
| PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-PROTEIN-CARRIER CONJUGATES | 2018 |
|
RU2784449C2 |
| POLYVALENT ASSOCIATED DIPHTHERIA, TETANUS TOXOIDS AND PERTUSSIS POLIOVIRUS VACCINES | 1997 |
|
RU2194531C2 |
